Endoscopic Sinus Surgery for Type-2 CRS wNP: An Endotype-Based Retrospective Study.
Saeed Alsharif, Karin Jonstam, Thibaut van Zele...
https://pubmed.ncbi.nlm.nih.gov/30663058/Actively Recruiting
Led by Kafrelsheikh University · Updated on 2026-05-28
40
Participants Needed
1
Research Sites
13 weeks
Total Duration
Researchers are comparing two surgical methods for patients with chronic rhinosinusitis with nasal polyps CRSwNP that do not respond to usual treatments. This study focuses on evaluating the safety and effectiveness of reboot surgery, which removes all inflamed sinus mucosa, against conventional full house functional endoscopic sinus surgery FESS. The goal is to see which approach reduces polyp recurrence, improves quality of life, decreases steroid use, and lowers complications over 24 months. Participants will be randomly assigned to one of two groups one undergoing reboot surgery involving complete removal of inflamed mucosa down to the bone, and the other receiving conventional FESS where healthy mucosa is preserved. This study will track outcomes including recurrence rates, symptom-free periods, quality of life improvements measured by SNOT-22 scores, and complication rates such as bleeding or infection. Throughout the study, participants will have regular evaluations including endoscopic examinations to check for polyp recurrence. Researchers will monitor quality of life, steroid use, and complications over a 24-month period following surgery. The study aims to provide a detailed comparison of the two surgical techniques for managing refractory CRSwNP and will be conducted by Kafrelsheikh University starting in January 2026.
CONDITIONS
Th Study Wants to Compare the Best Technique for Sinus Operation in CRSWNP
A
Amr Maher Shady Kafr Elsheikh Hospital University, Doctor
S
Saad Elzayat Kafr Elsheikh Hospital University, professor
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Kafrelsheikh University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of surgery
Participants undergo one of two types of endoscopic nasal operations to treat chronic rhinosinusitis with nasal polyps: either the Reboot operation involving complete removal of inflamed mucosa, or a conventional FESS operation preserving healthy mucosa.
1 surgical visit (in-person)
Duration - Up to approximately 1 year
Participants are monitored for recovery and outcomes after their sinus surgery, including symptom relief and recurrence prevention.
Regular follow-up visits spread over the year
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Saeed Alsharif, Karin Jonstam, Thibaut van Zele...
https://pubmed.ncbi.nlm.nih.gov/30663058/W J Fokkens, V J Lund, C Hopkins...
https://pubmed.ncbi.nlm.nih.gov/32077450/Kafrelsheikh University
Lead Sponsor